{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:30:14Z","timestamp":1793838614721,"version":"4.6.1"},"reference-count":214,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DK128289 \\u2013 04"],"award-info":[{"award-number":["5R01DK128289 \\u2013 04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhep.2025.02.039","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:20:06Z","timestamp":1741303206000},"page":"239-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis"],"prefix":"10.1016","volume":"83","author":[{"given":"Andressa","family":"de Zawadzki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-140X","authenticated-orcid":false,"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-0088","authenticated-orcid":false,"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-1293","authenticated-orcid":false,"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.02.039_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102706","article-title":"Profiling and targeting connective tissue remodeling in autoimmunity - a novel paradigm for diagnosing and treating chronic diseases","volume":"20","author":"Karsdal","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2025.02.039_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis \u2013 their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jhep.2025.02.039_bib3","doi-asserted-by":"crossref","first-page":"G807","DOI":"10.1152\/ajpgi.00447.2014","article-title":"Novel insights into the function and dynamics of extracellular matrix in liver fibrosis","volume":"308","author":"Karsdal","year":"2015","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2025.02.039_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/jso.21709","article-title":"Tumor microenvironment and progression","volume":"103","author":"Dvorak","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-475X.2007.00283.x","article-title":"Why chronic wounds will not heal: a novel hypothesis","volume":"16","author":"Bjarnsholt","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jhep.2025.02.039_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41590-023-01551-9","article-title":"Immunology of human fibrosis","volume":"24","author":"Bhattacharya","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000254","article-title":"Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease","volume":"7","author":"Karsdal","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/liv.15270","article-title":"An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution","volume":"42","author":"Pehrsson","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/liv.14390","article-title":"Collagen biology and non-invasive biomarkers of liver fibrosis","volume":"40","author":"Karsdal","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal","volume":"29","author":"Weng","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhep.2025.02.039_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"Loffek","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2025.02.039_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bpg.2011.02.011","article-title":"Anti-fibrogenic strategies and the regression of fibrosis","volume":"25","author":"Kisseleva","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.matbio.2018.02.020","article-title":"Therapeutic approaches to control tissue repair and fibrosis: extracellular matrix as a game changer","volume":"71\u201372","author":"Walraven","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/qjmed\/hcs069","article-title":"Liver fibrosis: a bidirectional model of fibrogenesis and resolution","volume":"105","author":"Ramachandran","year":"2012","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib19","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","article-title":"Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis","volume":"178","author":"Fallowfield","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100841","article-title":"Principles of cell circuits for tissue repair and fibrosis","volume":"23","author":"Adler","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.jhep.2025.02.039_bib23","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jhep.2025.02.039_bib24","article-title":"Cold and hot fibrosis define clinically distinct cardiac pathologies.pdf","volume":"16","author":"Miyara","year":"2025","journal-title":"Cell Syst"},{"key":"10.1016\/j.jhep.2025.02.039_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2025.02.039_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34241-5","article-title":"Understanding fibrosis pathogenesis via modeling macrophage-fibroblast interplay in immune-metabolic context","volume":"13","author":"Setten","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071545","article-title":"Macrophage phenotypes regulate scar formation and chronic wound healing","volume":"18","author":"Hesketh","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2025.02.039_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.02.039_bib30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-23-1380","article-title":"Spatial architecture of myeloid and T cells orchestrates immune evasion and clinical outcome in lung cancer","volume":"14","author":"Enfield","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2025.02.039_bib31","article-title":"Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Chan","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages\u2019 promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2025.02.039_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000491","article-title":"Liver macrophages revisited: the expanding universe of versatile responses in a spatiotemporal context","volume":"8","author":"Guillot","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib34","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib35","article-title":"Key role of macrophages in the progression of hepatic fibrosis","volume":"9","author":"Ran","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/HEP.0000000000000576","article-title":"Bile duct-associated macrophages enter the spotlight in inflammatory cholestatic liver disease","volume":"79","author":"Peiseler","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.02.039_bib39","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib41","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice","volume":"147","author":"Yoshida","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.02.039_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277808","article-title":"Macrophages and platelets in liver fibrosis and hepatocellular carcinoma","volume":"14","author":"Casari","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/apt.13515","article-title":"Aspirin use is associated with lower indices of liver fibrosis among adults in the United States","volume":"43","author":"Jiang","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945063","article-title":"Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis","volume":"13","author":"Kokubo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2011.03465.x","article-title":"The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases","volume":"134","author":"Pappu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2025.02.039_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cytogfr.2011.11.003","article-title":"Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory?","volume":"22","author":"Billiau","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jhep.2025.02.039_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi4613","article-title":"Transforming growth factor\u2013\u03b21 in regulatory T cell biology","volume":"7","author":"Moreau","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib48","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.02.039_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2015.00081","article-title":"The elusive antifibrotic macrophage","volume":"2","author":"Adhyatmika","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875041901205010001","article-title":"Definition of inflammation, causes of inflammation and possible anti-inflammatory strategies","volume":"5","author":"Stankov","year":"2012","journal-title":"Open Inflamm J"},{"key":"10.1016\/j.jhep.2025.02.039_bib52","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.02.039_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122310119","article-title":"pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages","volume":"119","author":"Kaps","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2025.02.039_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/14779072.2016.1147348","article-title":"Myofibroblast secretome and its auto-\/paracrine signaling","volume":"14","author":"Bomb","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113801","article-title":"Immune and non-immune inflammatory cells involved in autoimmune fibrosis: new discoveries","volume":"12","author":"Sisto","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib58","first-page":"E952","article-title":"Divergent functions of endotrophin on different cell populations in adipose tissue","volume":"311","author":"Zhao","year":"2016","journal-title":"Am J Physiol Metab"},{"key":"10.1016\/j.jhep.2025.02.039_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2024.06.003","article-title":"The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases","volume":"132","author":"Genovese","year":"2024","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00125-016-4130-1","article-title":"Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPAR\u03b3 agonist treatment","volume":"60","author":"Sun","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2025.02.039_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/endrev\/bnad036","article-title":"Endotrophin, a key marker and driver for fibroinflammatory disease","volume":"45","author":"Henriksen","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhep.2025.02.039_bib62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.matbio.2022.12.004","article-title":"What does it take to be a collagen receptor?","volume":"115","author":"Farndale","year":"2023","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1242\/jcs.188672","article-title":"The integrin-collagen connection - a glue for tissue repair?","volume":"129","author":"Zeltz","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791453","article-title":"Immune modulatory properties of collagen in cancer","volume":"12","author":"R\u00f8mer","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/polym14050876","article-title":"The molecular interaction of collagen with cell receptors for biological function","volume":"14","author":"Elango","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jhep.2025.02.039_bib66","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0006-291X(92)91834-D","article-title":"Affinity of integrins for damaged extracellular matrix: \u03b1v\u03b23 binds to denatured collagen type I through RGD sites","volume":"182","author":"Davis","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1097-2765(00)80003-9","article-title":"The discoidin domain receptor tyrosine kinases are activated by collagen","volume":"1","author":"Vogel","year":"1997","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2025.02.039_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00125","article-title":"Collagen kinase receptors as potential therapeutic targets in metastatic colon cancer","volume":"10","author":"Lafitte","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib70","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI200112373","article-title":"DDR2 receptor promotes MMP-2\u2013mediated proliferation and invasion by hepatic stellate cells","volume":"108","author":"Olaso","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.02.039_bib71","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1074\/jbc.M116.770057","article-title":"Discoidin domain receptor 2 mediates collagen-induced activation of membrane-Type 1 matrix metalloproteinase in human fibroblasts","volume":"292","author":"Majkowska","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.02.039_bib72","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1189\/jlb.0907609","article-title":"The inhibitory collagen receptor LAIR-1 (CD305)","volume":"83","author":"Meyaard","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2974753","article-title":"Expression of LAIR-1 (CD305) on human blood monocytes as a marker of hepatic cirrhosis progression","volume":"2019","author":"Mart\u00ednez-Esparza","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib74","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.trecan.2023.06.002","article-title":"Collagen architecture and signaling orchestrate cancer development","volume":"9","author":"Su","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jhep.2025.02.039_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/192543","article-title":"Toll-like receptor signaling and liver fibrosis","volume":"2010","author":"Aoyama","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhep.2025.02.039_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jhep.2025.02.039_bib77","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/eji.201545986","article-title":"OSCAR-collagen signaling in monocytes plays a proinflammatory role and may contribute to the pathogenesis of rheumatoid arthritis","volume":"46","author":"Schultz","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641162","article-title":"Role of OSCAR signaling in osteoclastogenesis and bone disease","volume":"9","author":"Nedeva","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib79","first-page":"559","article-title":"In vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"CMGH"},{"key":"10.1016\/j.jhep.2025.02.039_bib80","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","article-title":"Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease","volume":"77","author":"Mitten","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ceb.2010.08.015","article-title":"Dynamic interplay between the collagen scaffold and tumor evolution","volume":"22","author":"Egeblad","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2021.10.002","article-title":"Mechanical communication in fibrosis progression","volume":"32","author":"Long","year":"2022","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib83","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1242\/jcs.180539","article-title":"Mechanical signals regulate and activate SNAIL1 protein to control the fibrogenic response of cancer-associated fibroblasts","volume":"129","author":"Zhang","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib84","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.22193","article-title":"The role of matrix stiffness in regulating cell behavior","volume":"47","author":"Wells","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib85","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib86","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/cam4.303","article-title":"Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer","volume":"3","author":"Willumsen","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib87","series-title":"Biochemistry of collagens, laminins and elastin","author":"Karsdal","year":"2016"},{"key":"10.1016\/j.jhep.2025.02.039_bib88","first-page":"73","article-title":"The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR\u03b1-mAb treatment in rheumatoid arthritis patients","volume":"37","author":"Mortensen","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib89","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/acs.jproteome.7b00191","article-title":"Characterization of the extracellular matrix of normal and diseased tissues using proteomics","volume":"16","author":"Naba","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30969","article-title":"Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis?","volume":"71","author":"Karsdal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30457-y","article-title":"An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis","volume":"8","author":"Luo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib92","article-title":"Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease","volume":"3","author":"Vesterhus","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib93","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/liv.15595","article-title":"Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease","volume":"43","author":"Johansen","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhepr.2019.06.004","article-title":"Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease","volume":"1","author":"Boyle","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib95","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib96","article-title":"Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure","volume":"3","author":"Kerbert","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib97","doi-asserted-by":"crossref","DOI":"10.2217\/hep-2020-0030","article-title":"Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma","volume":"8","author":"Leeming","year":"2021","journal-title":"Hepatic Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib98","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.clinre.2015.05.005","article-title":"Liver fibrosis: common mechanisms and antifibrotic therapies","volume":"39","author":"Schuppan","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib99","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.615978","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib101","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1038\/550S102a","article-title":"Fighting the fatty liver","volume":"550","author":"Drew","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.02.039_bib102","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib103","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000001059","article-title":"A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients","volume":"116","author":"Eslam","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154958","article-title":"Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD","volume":"128","author":"Tang","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2025.02.039_bib105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)01541-1","article-title":"WED-196 Analyses of fibrosis biomarkers PRO-C3 and ELF in resmetirom treated patients from MAESTRO-NASH, a 52 Week NASH\/MASH serial liver biopsy study","volume":"80","author":"Anstee","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib107","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/apt.16567","article-title":"Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation","volume":"54","author":"Thiele","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib108","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000467","article-title":"Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis","volume":"8","author":"Thorburn","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137302","article-title":"Markers of collagen remodeling detect clinically significant fibrosis in chronic hepatitis C patients","volume":"10","author":"Nielsen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.02.039_bib110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib111","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib112","article-title":"PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease","volume":"5","author":"Nielsen","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib113","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/liv.15365","article-title":"Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease","volume":"42","author":"Simbrunner","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib114","first-page":"G1009","article-title":"Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy","volume":"311","author":"Karsdal","year":"2016","journal-title":"Am J Physiol Liver Physiol"},{"key":"10.1016\/j.jhep.2025.02.039_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cgh.2023.04.011","article-title":"Pegbelfermin in patients with nonalcoholic steatohepatitis and stage 3 fibrosis (falcon 1): a randomized phase 2b study","volume":"22","author":"Loomba","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib116","article-title":"Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial","volume":"5","author":"Brown","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep4.1657","article-title":"Effects of resmetirom on noninvasive endpoints in a 36-week phase 2 active treatment extension study in patients with NASH","volume":"5","author":"Harrison","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib118","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41591-019-0599-8","article-title":"Safety profile of autologous macrophage therapy for liver cirrhosis","volume":"25","author":"Moroni","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103447","article-title":"Endotrophin: nominated for best supporting actor in the fibro-inflammatory saga","volume":"69","author":"Scherer","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhep.2025.02.039_bib120","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s12276-020-00520-8","article-title":"The impact of endotrophin on the progression of chronic liver disease","volume":"52","author":"Kim","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib121","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/00365521.2021.1879249","article-title":"Serum levels of endotrophin are associated with nonalcoholic steatohepatitis","volume":"56","author":"Hagstr\u00f6m","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib122","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14737159.2023.2215928","article-title":"Blood-based biomarkers of chronic inflammation","volume":"23","author":"Pritzker","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jhep.2025.02.039_bib123","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ni.3828","article-title":"Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib124","article-title":"New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.jhep.2025.02.039_bib125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jceh.2017.09.004","article-title":"Matrix metalloproteinases (MMPs) in liver diseases","volume":"7","author":"Naim","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib126","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/apt.13819","article-title":"Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury","volume":"44","author":"Nielsen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib127","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","article-title":"Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover","volume":"22","author":"Siebuhr","year":"2014","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.jhep.2025.02.039_bib128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/1354750X.2015.1105497","article-title":"Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis","volume":"20","author":"Kjelgaard-Petersen","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/j.jhep.2025.02.039_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054504","article-title":"Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis","volume":"8","author":"Bay-Jensen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.02.039_bib130","article-title":"Cardiac dysfunction in rheumatoid arthritis: the role of inflammation","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2025.02.039_bib131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib132","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 Mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jhep.2025.02.039_bib133","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0049-0172(87)90020-5","article-title":"Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy","author":"Roschmann","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jhep.2025.02.039_bib134","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0440-6","article-title":"High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study","volume":"17","author":"Sand","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib135","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/labinvest.2012.57","article-title":"Extracellular matrix alterations and acute inflammation; Developing in parallel during early induction of pulmonary fibrosis","volume":"92","author":"Rydell-T\u00f6rm\u00e4nen","year":"2012","journal-title":"Lab Investig"},{"key":"10.1016\/j.jhep.2025.02.039_bib136","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01801-0","article-title":"Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis","volume":"22","author":"Jessen","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib137","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib138","first-page":"403","article-title":"Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology","volume":"4","author":"Vassiliadis","year":"2012","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-022-02967-8","article-title":"Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy","volume":"24","author":"Holm Nielsen","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MCG.0000000000001341","article-title":"The citrullinated and MMP-degraded vimentin biomarker (VICM) predicts early response to anti-tnf\u03b1 treatment in Crohn\u2019s disease","volume":"55","author":"Mortensen","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib141","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MCG.0000000000001341","article-title":"The citrullinated and MMP-degraded vimentin biomarker (VICM) predicts early response to anti-TNF\u03b1 treatment in Crohn\u2019s disease","volume":"55","author":"Mortensen","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.02.039_bib142","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.37843","article-title":"Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression","volume":"65","author":"Bay-Jensen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2025.02.039_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101184","article-title":"Characterization of the roles of vimentin in regulating the proliferation and migration of HSCs during hepatic fibrogenesis","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2025.02.039_bib144","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/JLB.5A1217-501R","article-title":"Leukocyte extracellular vesicle concentration is inversely associated with liver fibrosis severity in NAFLD","volume":"104","author":"Welsh","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib146","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/joim.12054","article-title":"Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality","volume":"274","author":"Zimmermann","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib147","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib148","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.02.039_bib149","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","author":"Konikoff","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2025.02.039_bib151","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ecco-jcc\/jjac047","article-title":"A specific calprotectin neo-epitope [CPa9-HNE] in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity","volume":"16","author":"Mortensen","year":"2022","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2025.02.039_bib152","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1096\/fj.14-268425","article-title":"Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice","volume":"30","author":"Liu","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2025.02.039_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"10.1016\/j.jhep.2025.02.039_bib154","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1221557","article-title":"Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1 \u03b1 induced IL-10","volume":"5","author":"Ambade","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jhep.2025.02.039_bib155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2025.02.039_bib156","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib157","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.02.039_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12102786","article-title":"Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade","volume":"12","author":"Jensen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.02.039_bib159","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40425-018-0474-z","article-title":"Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients","volume":"6","author":"Jensen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jhep.2025.02.039_bib160","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6600832","article-title":"Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy","volume":"88","author":"Hanke","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2025.02.039_bib161","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib162","article-title":"Biomarkers of type IV collagen turnover reflect disease activity in patients with early-stage non-alcoholic fatty liver (NAFL)","volume":"12","author":"L\u00f8nsmann","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jhep.2025.02.039_bib163","doi-asserted-by":"crossref","DOI":"10.1186\/1755-1536-4-22","article-title":"Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis","volume":"4","author":"Veidal","year":"2011","journal-title":"Fibrogenes Tissue Repair"},{"key":"10.1016\/j.jhep.2025.02.039_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20462","article-title":"Comprehensive analysis of basement membrane and immune checkpoint related lncRNA and its prognostic value in hepatocellular carcinoma via machine learning","volume":"9","author":"Jin","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jhep.2025.02.039_bib165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/annonc\/mdy551","article-title":"Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors","volume":"30","author":"Heinhuis","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib166","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","article-title":"Safety of combining radiotherapy with immune-checkpoint inhibition","volume":"15","author":"Hwang","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhep.2025.02.039_bib167","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","article-title":"Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma","volume":"72","author":"Cheng","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib168","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053190","article-title":"Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)","volume":"11","author":"Brennan","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2025.02.039_bib169","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbadis.2012.10.005","article-title":"Integrin-mediated regulation of TGF\u03b2 in fibrosis","volume":"1832","author":"Henderson","year":"2013","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"10.1016\/j.jhep.2025.02.039_bib170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.matbio.2014.08.001","article-title":"Post-translational modifications of integrin ligands as pathogenic mechanisms in disease","volume":"40","author":"Zeltz","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.04.004","article-title":"DDR1 role in fibrosis and its pharmacological targeting","volume":"1866","author":"Moll","year":"2019","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib172","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.matbio.2013.12.002","article-title":"Discoidin domain receptors in disease","volume":"34","author":"Borza","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhep.2025.02.039_bib173","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1538-7836.2004.00665.x","article-title":"The role of collagen in thrombosis and hemostasis","volume":"2","author":"Farndale","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2025.02.039_bib174","doi-asserted-by":"crossref","DOI":"10.1186\/ar4266","article-title":"Serological identification of fast progressors of structural damage with rheumatoid arthritis","volume":"15","author":"Siebuhr","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib175","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02340-7","article-title":"The Janus kinase 1\/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis","volume":"22","author":"Thudium","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.06.376","article-title":"33530 Novel serological biomarkers are associated with disease severity and systemic inflammation in patients with hidradenitis suppurativa","volume":"87","author":"Groen","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhep.2025.02.039_bib177","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/joim.12819","article-title":"A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis","volume":"285","author":"Holm Nielsen","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23458-4","article-title":"Matrix metalloproteinase mediated type I collagen degradation is an independent predictor of increased risk of acute myocardial infarction in postmenopausal women","volume":"8","author":"Bertelsen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149329","article-title":"Neo-epitopes-fragments of cartilage and connective tissue degradation in early rheumatoid arthritis and unclassified arthritis","volume":"11","author":"Maijer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.02.039_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13547500903295873","article-title":"Application of biochemical markers in development of drugs for treatment of osteoarthritis","volume":"15","author":"Qvist","year":"2010","journal-title":"Biomarkers"},{"key":"10.1016\/j.jhep.2025.02.039_bib181","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.3390\/ijms151018789","article-title":"Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes","volume":"15","author":"Gudmann","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib182","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib183","doi-asserted-by":"crossref","first-page":"G1009","DOI":"10.1152\/ajpgi.00283.2016","article-title":"Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy","volume":"311","author":"Karsdal","year":"2016","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2025.02.039_bib184","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chest.2016.08.1440","article-title":"Systemic biomarkers of collagen and elastin turnover are associated with clinically relevant outcomes in COPD","volume":"151","author":"Stolz","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jhep.2025.02.039_bib185","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-015-0225-3","article-title":"Accelerated extracellular matrix turnover during exacerbations of COPD","volume":"16","author":"Sand","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib186","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hep4.1135","article-title":"Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis","volume":"2","author":"Praktiknjo","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.02.039_bib187","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/cancers11081186","article-title":"Clinical relevance of collagen protein degradation markers C3M and C4M in the serum of breast cancer patients treated with neoadjuvant therapy in the GeparQuinto trial","volume":"11","author":"Banys-Paluchowski","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.02.039_bib188","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/liv.14070","article-title":"Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis","volume":"39","author":"Lehmann","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.02.039_bib189","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.3390\/cancers15174323","article-title":"Revisiting circulating extracellular matrix fragments as disease markers in myelofibrosis and related neoplasms","volume":"15","author":"Hasselbalch","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.02.039_bib190","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ijc.34356","article-title":"Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer","volume":"152","author":"Christensen","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2025.02.039_bib191","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33100-7","article-title":"Quantification of extracellular matrix remodeling for the non-invasive identification of graft fibrosis after liver transplantation","volume":"13","author":"Engel","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2025.02.039_bib192","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2337\/dc17-2392","article-title":"Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria","volume":"41","author":"Rasmussen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2025.02.039_bib193","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200091","article-title":"Endotrophin, a collagen VI formation\u2013derived peptide, in heart failure","volume":"1","author":"Chirinos","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhep.2025.02.039_bib194","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apt.15812","article-title":"Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy","volume":"52","author":"Wiese","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib195","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/biom12091315","article-title":"Plasma kallikrein-activated TGF-\u03b2 is prognostic for poor overall survival in patients with pancreatic ductal adenocarcinoma and associates with increased fibrogenesis","volume":"12","author":"Pedersen","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jhep.2025.02.039_bib196","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12931-017-0509-x","article-title":"Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD","volume":"18","author":"Bihlet","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib197","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-016-4094-1","article-title":"Serum endotrophin identifies optimal responders to PPAR\u03b3 agonists in type 2 diabetes","volume":"60","author":"Karsdal","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2025.02.039_bib198","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12931-020-01461-6","article-title":"Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort","volume":"21","author":"R\u00f8nnow","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib199","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1093\/ecco-jcc\/jjy222.425","article-title":"P301 A serological biomarker of type VIII collagen that contains the anti-angiogenic signalling molecule, vastatin, is associated with the extension of disease in ulcerative colitis","volume":"13","author":"Lindholm","year":"2019","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2025.02.039_bib200","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2016.56","article-title":"Vastatin, an endogenous antiangiogenesis polypeptide that is lost in hepatocellular carcinoma, effectively inhibits tumor metastasis","volume":"24","author":"Shen","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib201","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/15384047.2018.1550571","article-title":"Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer","volume":"20","author":"Willumsen","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jhep.2025.02.039_bib202","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.yexcr.2005.11.015","article-title":"Antiangiogenesis in cancer therapy\u2014endostatin and its mechanisms of action","volume":"312","author":"Folkman","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib203","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1096\/fj.04-2134rev","article-title":"Physiological role of collagen XVIII and endostatin","volume":"19","author":"Marneros","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2025.02.039_bib204","doi-asserted-by":"crossref","first-page":"i214","DOI":"10.1093\/ecco-jcc\/jjab232.255","article-title":"P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease","volume":"16","author":"Bourgonje","year":"2022","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2025.02.039_bib205","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1093\/ecco-jcc\/jjab076.440","article-title":"P316 Human neutrophil elastase derived fragment of calprotectin (S100a9) is a serum biomarker (CPa9-HNE) for monitoring of anti-TNF\u03b1 treatment response in Crohn\u2019s disease","volume":"15","author":"Mortensen","year":"2021","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2025.02.039_bib206","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.3390\/ijms23158137","article-title":"Serological biomarkers of extracellular matrix turnover and neutrophil activity are associated with long-term use of vedolizumab in patients with Crohn\u2019s disease","volume":"23","author":"Alexdottir","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.039_bib207","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.3390\/jcm12247589","article-title":"A serological neoepitope biomarker of neutrophil elastase-degraded calprotectin, associated with neutrophil activity, identifies idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease more effectively than total calprotectin","volume":"12","author":"Hansen","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2025.02.039_bib208","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/1538-7445.AM2021-386","article-title":"Abstract 386: evaluation of CPa9-HNE - a peripheral biomarker based on neutrophil extracellular traps (NETs) - for predicting outcome in patients with metastatic melanoma treated with anti-PD-1 therapy","volume":"81","author":"Jensen","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.02.039_bib209","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.18632\/oncotarget.27332","article-title":"Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease","volume":"10","author":"Nissen","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2025.02.039_bib210","first-page":"PA4060","article-title":"Vimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)","author":"Sim\u00f5es","year":"2023","journal-title":"Transl Sci Eur Respir Soc"},{"key":"10.1016\/j.jhep.2025.02.039_bib211","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ecco-jcc\/jjv123","article-title":"Fragments of citrullinated and MMP-degraded vimentin and MMP-degraded type III collagen are novel serological biomarkers to differentiate Crohn\u2019s disease from ulcerative colitis","volume":"9","author":"Mortensen","year":"2015","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2025.02.039_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.634409","article-title":"Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease","volume":"11","author":"Lambrecht","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2025.02.039_bib213","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cells9051175","article-title":"Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure","volume":"9","author":"Nielsen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2025.02.039_bib214","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.3390\/molecules27113516","article-title":"A prospective viewpoint on neurological diseases and their biomarkers","volume":"27","author":"Zehravi","year":"2022","journal-title":"Molecules"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2025.12.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000}},{"DOI":"10.1016\/j.jhep.2025.12.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:47Z","timestamp":1783032407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":214,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0168827825001485"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.039","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}